The Beauty Health Company (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
1.610
-0.050 (-3.01%)
Nov 4, 2024, 4:00 PM EST - Market closed
The Beauty Health Company Analyst Ratings
Total Analysts
10
Consensus Rating
Hold
Price Target
$2.29
Upside
+42.24%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $2 → $1.25 | Hold | Maintains | $2 → $1.25 | -22.36% | Aug 12, 2024 |
| Piper Sandler | Piper Sandler | Sell Reiterates $1.5 → $1 | Sell | Reiterates | $1.5 → $1 | -37.89% | Aug 9, 2024 |
| Stifel | Stifel | Hold Maintains $4 → $2 | Hold | Maintains | $4 → $2 | +24.22% | Jul 26, 2024 |
| Piper Sandler | Piper Sandler | Sell Maintains $2.5 → $1.5 | Sell | Maintains | $2.5 → $1.5 | -6.83% | Jul 11, 2024 |
| DA Davidson | DA Davidson | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +210.56% | May 13, 2024 |
| TD Cowen | TD Cowen | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +86.34% | May 13, 2024 |
| Piper Sandler | Piper Sandler | Sell Maintains $3 → $2.5 | Sell | Maintains | $3 → $2.5 | +55.28% | May 10, 2024 |
| DA Davidson | DA Davidson | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +210.56% | Mar 15, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $3 → $4 | Hold | Maintains | $3 → $4 | +148.45% | Mar 14, 2024 |
| Piper Sandler | Piper Sandler | Sell Reiterates $2 → $3 | Sell | Reiterates | $2 → $3 | +86.34% | Mar 13, 2024 |
| Stifel | Stifel | Hold Reiterates $3 → $4 | Hold | Reiterates | $3 → $4 | +148.45% | Mar 13, 2024 |
| TD Cowen | TD Cowen | Hold Maintains $2.5 → $4 | Hold | Maintains | $2.5 → $4 | +148.45% | Mar 13, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $2.5 → $3 | Hold | Maintains | $2.5 → $3 | +86.34% | Feb 29, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $11 → $1.5 | Strong Buy → Hold | Downgrades | $11 → $1.5 | -6.83% | Nov 15, 2023 |
| Stifel | Stifel | Hold Maintains $8 → $3 | Hold | Maintains | $8 → $3 | +86.34% | Nov 14, 2023 |
| Benchmark | Benchmark | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 14, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.